Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Sanders WE Jr, Sanders CC. Enterobacter spp.: pathogens poised to flourish at the turn of the century. Clin. Microbiol. Rev.10,220–241 (1997).▪ Exhaustive review on the Enterobacter genus that highlights microbiological, clinical and epidemiological features and antibiotic susceptibility.
  MedlineGoogle Scholar
• 2  Streit JM, Jones RN, Sader HS, Fritsche TR. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int. J. Antimicrob. Agents24,111–118 (2004).
  Medline CASGoogle Scholar
• 3  Hidron AI, Edwards JR, Patel J et al.; for the National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect. Control Hosp. Epidemiol.29(11),996–1011 (2008).
  MedlineGoogle Scholar
• 4  Wisplinghoff H, Bischoff T, Tallent SM et al. Nosocomial bloodstream infections in us hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis.39,309–317 (2004).
  MedlineGoogle Scholar
• 5  Paauw A, Caspers MP, Schuren FH et al. Genomic diversity within the Enterobacter cloacae complex. PLoS One3,e3018(2008).▪▪ Utilization of four genetic approaches for discriminating within the Enterobacter cloacae complex.
  MedlineGoogle Scholar
• 6  Hoffmann H, Roggenkamp A. Population genetics of the nomenspecies Enterobacter cloacae. Appl. Environ. Microbiol.69,5306–5318 (2003).▪▪ Genetic clustering highlighting taxonomic and epidemiological characteristics of the E. cloacae complex.
  Medline CASGoogle Scholar
• 7  Hormaeche E, Edwards PR. A proposed genus Enterobacter. Int. Bull. Bacteriol. Nomencl. Taxon.10,71–74 (1960).
  Google Scholar
• 8  Morand PC, Billoet A, Rottman M et al. Specific distribution within the Enterobacter cloacae complex of strains isolated from infected orthopedic implants. J. Clin. Microbiol.47(8),2489–2495 (2009).
  Medline CASGoogle Scholar
• 9  Wang GF, Xie GL, Zhu B et al. Identification and characterization of the Enterobacter complex causing mulberry (Morus alba) wilt disease in China. Eur. J. Plant Pathol.126,465–478 (2010).
  CASGoogle Scholar
• 10  O’Hara CM, Steigerwalt AG, Hill BC, Farmer JJ III, Fanning GG, Brenner DJ. Enterobacter hormaechei, a new species of the family Enterobacteriaceae formerly known as enteric group 75. J. Clin. Microbiol.27,2046–2049 (1989).
  MedlineGoogle Scholar
• 11  Hoffmann H, Stindl S, Ludwig W et al.Enterobacter hormaechei subsp. oharae subsp. nov., E. hormaechei subsp. hormaechei comb. nov., and E. hormaechei subsp. steigerwaltii subsp. nov., three new subspecies of clinical importance J. Clin. Microbiol.43,3297–3303 (2005).
  Medline CASGoogle Scholar
• 12  Hoffmann H, Stindl S, Stumpf A et al. Description of Enterobacter ludwigii sp. nov., a novel Enterobacter species of clinical relevance. Syst. Appl. Microbiol.28(3),206–212 (2005).
  Medline CASGoogle Scholar
• 13  Hoffmann H, Stindl S, Ludwig W et al. Reassignment of Enterobacter dissolvens to Enterobacter cloacae as E. cloacae subspecies dissolvens comb. nov. and emended description of Enterobacter asburiae and Enterobacter kobei. Syst. Appl. Microbiol.28(3),196–205 (2005).
  Medline CASGoogle Scholar
• 14  Mshana SE, Gerwing L, Minde M et al. Outbreak of a novel Enterobacter sp. carrying bla_CTX-M-15 in a neonatal unit of a tertiary care hospital in Tanzania. Int. J. Antimicrob. Agents.38(3),265–269 (2011).
  Medline CASGoogle Scholar
• 15  Pavlovic M, Konrad R, Iwobi AN, Sing A, Busch U, Huber I. A dual approach employing MALDI-TOF MS and real-time PCR for fast species identification within the Enterobacter cloacae complex. FEMS Microbiol. Lett.328,46–53 (2012).
  Medline CASGoogle Scholar
• 16  Hoffmann H, Schmoldt S, Trqlzsch K et al. Nosocomial urosepsis caused by Enterobacter kobei with aberrant phenotype. Diagn. Microbiol. Infect. Dis.53,143–147 (2005).
  MedlineGoogle Scholar
• 17  Townsend SM, Hurrell E, Caubilla-Barron J, Loc-Carrillo C, Forsythe SJ. Characterization of an extended-spectrum betalactamase Enterobacter hormaechei nosocomial outbreak, and other Enterobacter hormaechei misidentified as Cronobacter (Enterobacter) sakazakii. Microbiology154,3659–3667 (2008).
  Medline CASGoogle Scholar
• 18  Garaizar J, Kaufmann ME, Pitt TL. Comparison of ribotyping with conventional methods for the type identification of Enterobacter cloacae. J. Clin. Microbiol.29,1303–1307 (1991).
  Medline CASGoogle Scholar
• 19  Haertl R, Bandlow G. Epidemiological fingerprinting of Enterobacter cloacae by small-fragment restriction endonuclease analysis and pulsed-field gel electrophoresis of genomic restriction fragments. J. Clin. Microbiol.31,128–133 (1993).
  Medline CASGoogle Scholar
• 20  Williams JGK, Kubelick AR, Livak KJ, Rafalski JA, Tingey SV. DNA polymorphisms amplified by arbitrary primers are useful genetic markers. Nucleic Acids Res.18,6531–6535 (1990).
  Medline CASGoogle Scholar
• 21  Stumpf AN, Roggenkamp A, Hoffmann H. Specificity of enterobacterial repetitive intergenic consensus and repetitive extragenic palindromic polymerase chain reaction for the detection of clonality within the Enterobacter cloacae complex. Diagn. Microbiol. Infect. Dis.53(1),9–16 (2005).
  Medline CASGoogle Scholar
• 22  Barnes AI, Ortiz C, Paraje MG, Balanzino LE, Albesa I. Purification and characterization of a cytotoxin from Enterobacter cloacae. Can. J. Microbiol.43(8),729–733 (1997).
  Medline CASGoogle Scholar
• 23  Stuber K, Frey J, Burnens AP, Kuhnert P. Detection of type III secretion genes as a general indicator of bacterial virulence. Mol. Cell. Probe17,25–32 (2003).
  Medline CASGoogle Scholar
• 24  Krzyminska S, Mokracka J, Koczura R, Kaznowski A. Cytotoxic activity of Enterobacter cloacae human isolates. FEMS Immunol. Med. Microbiol.56,248–252 (2009).
  Medline CASGoogle Scholar
• 25  Krzyminska S, Koczura R, Mokracka J, Puton T, Kaznowski A. Isolates of the Enterobacter cloacae complex induce apoptosis of human intestinal epithelial cells. Microb. Pathog.49,83–89 (2010).
  Medline CASGoogle Scholar
• 26  Olsén A, Arnqvist A, Hammar M, Normark S. Environmental regulation of curli production in Escherichia coli. Infect. Agents Dis.2(4),272–274 (1993).
  Medline CASGoogle Scholar
• 27  Zogaj X, Bokranz W, Nimtz M, Romling U. Production of cellulose and curli fimbriae by members of the family Enterobacteriaceae isolated from the human gastrointestinal tract. Infect. Immun.71(7),4151–4158 (2003).
  Medline CASGoogle Scholar
• 28  Kim SM, Lee HW, Choi YW et al. Involvement of curli fimbriae in the biofilm formation of Enterobacter cloacae. J. Microbiol.50(1),175–178 (2012).
  Medline CASGoogle Scholar
• 29  Lee SO, Kim YS, Kim BN, Kim MN, Woo JH, Ryu J. Impact of previous use of antibiotics on development of resistance to extended-spectrum cephalosporins in patients with enterobacter bacteremia. Eur. J. Clin. Microbiol. Infect. Dis.8,577–581 (2002).
  Google Scholar
• 30  Musil I, Jensen V, Schilling J, Ashdown B, Kent T. Enterobacter cloacae infection of an expanded polytetrafluoroethylene femoral–popliteal bypass graft: a case report. J. Med. Case Rep.9(4),131(2010).
  Google Scholar
• 31  Dalben M, Varkulja G, Basso M et al. Investigation of an outbreak of Enterobacter cloacae in a neonatal unit and review of the literature. J. Hosp. Infect.70,7–14 (2008).
  Medline CASGoogle Scholar
• 32  van Nierop WH, Duse AG, Stewart RG, Bilgeri YR, Koornhof HJ. Molecular epidemiology of an outbreak of Enterobacter cloacae in the neonatal intensive care unit of a provincial hospital in Gauteng, South Africa. J. Clin. Microbiol.36,3085–3087 (1998).
  Medline CASGoogle Scholar
• 33  Kuboyama RH, de Oliveira HB, Moretti-Branchini ML. Molecular epidemiology of systemic infection caused by Enterobacter cloacae in a high-risk neonatal intensive care unit. Infect. Control Hosp. Epidemiol.24,490–494 (2003).
  MedlineGoogle Scholar
• 34  Ren Y, Ren Y, Zhou Z et al. Complete genome sequence of Enterobacter cloacae subsp. cloacae type strain ATCC 13047. J. Bacteriol.192(9),2463–2464 (2010).
  Medline CASGoogle Scholar
• 35  Edwards PR, Fife MA. Capsular types of Klebsiella. J. Infect. Dis.91,92–104 (1952).
  Medline CASGoogle Scholar
• 36  Edwards PR, Fife MS. Eleven undescribed Arizona serotypes isolated from man. Antonie Van Leeuwenhoek28,402–404 (1962).
  Google Scholar
• 37  Fife MA, McWhorter AC, Edwards PR. Ten new Arizona serotypes isolated from animals and animal food products. Antonie Van Leeuwenhoek28,369–372 (1962).
  Medline CASGoogle Scholar
• 38  Manzano D, Rojo P, Zubero Z, Alvarez M, Santamaria JM, Cisterna R. [Polymicrobial bacteremia caused by Enterobacter gergoviae and Candida albicans.] Enferm. Infecc. Microbiol. Clin.9,186–187 (1991).
  Medline CASGoogle Scholar
• 39  Farmer JJ 3rd, Fanning GR, Davis BR et al.Escherichia fergusonii and Enterobacter taylorae, two new species of Enterobacteriaceae isolated from clinical specimens. J. Clin. Microbiol.21(1),77–81 (1985).
  Medline CASGoogle Scholar
• 40  Ewing WH, Fife MA. Enterobacter agglomerans (Beijerinck) comb. nov. (the Herbicola–Lathyri bacteria). Int. J. Syst. Bacteriol.22,4–11 (1972).
  Google Scholar
• 41  Farmer JJ III, Asbury MA, Hickman FW, Brenner DJ; Enterobacteriaceae Study Group. Enterobacter sakazakii: a new species of “Enterobacteriaceae” isolated from clinical specimens. Int. J. Syst. Bacteriol.30,569–584 (1980).
  Google Scholar
• 42  Grimont PAD, Grimont F, Farmer JJ III, Asbury MA. Cedecea davisae gen. nov., sp. nov. and Cedecea lapagei sp. nov., new Enterobacteriaceae from clinical specimens. Int. J. Syst. Bacteriol.31,317–326 (1981).
  Google Scholar
• 43  Brenner DJ, McWhorter AC, Kai A, Steigerwalt AG, Farmer JJ III. Enterobacter asburiae sp. nov., a new species found in clinical specimens, and reassignment of Erwinia dissolvens and Erwinia nimipressuralis to the genus Enterobacter as Enterobacter dissolvens comb. nov. and Enterobacter nimipressuralis comb. nov. J. Clin. Microbiol.23,1114–1120 (1986).
  Medline CASGoogle Scholar
• 44  Farmer JJ III, Davis BR, Hickman-Brenner FW et al. Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens. J. Clin. Microbiol.21,46–76 (1985).
  Medline CASGoogle Scholar
• 45  Davin-Regli A, Bosi C, Charrel R et al. A nosocomial outbreak due to Enterobacter cloacae strains with the E. hormaechei genotype in patients treated with fluoroquinolones. J. Clin. Microbiol.35,1008–1010 (1997).
  Medline CASGoogle Scholar
• 46  Paauw A, Caspers MPM, Leverstein-van Hall MA et al. Identification of resistance and virulence factors in an epidemic Enterobacter hormaechei outbreak strain. Microbiology155,1478–1488 (2009).
  Medline CASGoogle Scholar
• 47  Wenger PN, Tokars JI, Brennan P et al. An outbreak of Enterobacter hormaechei infection and colonization in an intensive care nursery. Clin. Infect. Dis.24(6),1243–1244 (1997).
  Medline CASGoogle Scholar
• 48  Campos LC, Lobianco LF, Seki LM, Santos RM, Asensi MD. Outbreak of Enterobacter hormaechei septicaemia in newborns caused by contaminated parenteral nutrition in Brazil. J. Hosp. Infect.66(1),95–97 (2007).
  Medline CASGoogle Scholar
• 49  Kosako Y, Tamura K, Sakazaki R, Miki K. Enterobacter kobei sp. nov., a new species of the family Enterobacteriaceae resembling Enterobacter cloacae. Curr. Microbiol.33,261–265 (1996).
  Medline CASGoogle Scholar
• 50  Farmer JJ. Enterobacteriaceae. In: Manual of Clinical Microbiology (6th Edition). Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (Eds). American Society for Microbiology, Washington, DC, USA, 438–449 (1994).
  Google Scholar
• 51  Ludwig W, Klenk HP. Overview: a phylogenetic backbone and taxonomic framework for procaryotic systematics, In: Bergey’s Manual of Systematic Bacteriology (2nd Edition). Garrity G (Ed.). Springer, NY, USA, 49–65 (2001).
  Google Scholar
• 52  Ludwig W, Strunk O, Westram R et al. ARB: a software environment for sequence data. Nucleic Acids Res.32,1363–1371 (2004).
  Medline CASGoogle Scholar
• 53  Stock I, Grüger T, Wiedemann B. Natural antibiotic susceptibility of strains of the Enterobacter cloacae complex. Int. J. Antimicrob. Agents.18(6),537–545 (2001).▪▪ Evaluation of a wide range of antibiotics tested against E. cloacae, Enterobacter hormaechei and Enterobacter asburiae strains, providing a database for their natural susceptibility.
  Medline CASGoogle Scholar
• 54  Kim DM, Jang SJ, Neupane GP et al.Enterobacter nimipressuralis as a cause of pseudobacteremia. BMC Infect. Dis.10,315(2010).
  MedlineGoogle Scholar
• 55  Scotta C, Juan C, Cabot G et al. Environmental microbiota represents a natural reservoir for dissemination of clinically relevant metallo-beta-lactamases. Antimicrob. Agents Chemother.55,5376–5379 (2011).
  Medline CASGoogle Scholar
• 56  George AJ. AmpC β-lactamases. Clin. Microbiol. Rev.22(1),161–182 (2009).
  MedlineGoogle Scholar
• 57  Roh KH, Song W, Chung HS et al. Chromosomal cephalosporinase in Enterobacter hormaechei as an ancestor of ACT-1 plasmid-mediated AmpC beta-lactamase. J. Med. Microbiol.61(1),94–100 (2012).
  Medline CASGoogle Scholar
• 58  Choi SH, Lee JE, Park SJ et al. Prevalence, microbiology, and clinical characteristics of extended-spectrum beta-lactamase-producing Enterobacter spp., Serratia marcescens, Citrobacter freundii, and Morganella morganii in Korea. Eur. J. Clin. Microbiol. Infect. Dis.26,557–561 (2007).
  MedlineGoogle Scholar
• 59  Smith Moland E, Sanders CC, Thomson KC. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among Escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam? J. Clin. Microbiol.36,2575–2579 (1998).
  MedlineGoogle Scholar
• 60  Tzelepi E, Giakkoupi P, Sofianou D, Loukova V, Kemeroglou A, Tsakris A. Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J. Clin. Microbiol.38(2),542–546 (2000).
  Medline CASGoogle Scholar
• 61  Tzouvelekis LS, Vatopoulos AC, Katsanis G, Tzelepi E. Rare case of failure by an automated system to detect extended-spectrum beta-lactamase in a cephalosporin-resistant Klebsiella pneumoniae isolate. J. Clin. Microbiol.37(7),2388(1999).
  Medline CASGoogle Scholar
• 62  Girlich D, Poirel L, Leelaporn A et al. Molecular epidemiology of the integronlocated VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J. Clin. Microbiol.39,175–182 (2001).
  Medline CASGoogle Scholar
• 63  Paterson DL. Resistance in Gram-negative bacteria: Enterobacteriaceae. Am. J. Med.119(6 Suppl. 1),S20–S28 (2006).
  Medline CASGoogle Scholar
• 64  Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev.18,657–686 (2005).
  Medline CASGoogle Scholar
• 65  Jiang X, Ni Y, Jiang Y et al. Outbreak of infection caused by Enterobacter cloacae producing the novel VEB-3 beta-lactamase in China. J. Clin. Microbiol.43(2),826–831 (2005).
  Medline CASGoogle Scholar
• 66  Ho PL, Shek RH, Chow KH et al. Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000–2002. J. Antimicrob. Chemother.55(3),326–332 (2005).
  Medline CASGoogle Scholar
• 67  Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis.8,159–166 (2008).
  Medline CASGoogle Scholar
• 68  Poirel L, Pitout JD, Nordmann P. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol.2(5),501–512 (2007).
  CASGoogle Scholar
• 69  Panagea T, Galani I, Souli M, Adamou P, Antoniadou A, Giamarellou H. Evaluation of CHROMagar™ KPC for the detection of carbapenemase-producing Enterobacteriaceae in rectal surveillance cultures. Int. J. Antimicrob. Agents37(2),124–128 (2011).
  Medline CASGoogle Scholar
• 70  Cohen Stuart J, Leverstein-Van Hall MA; Dutch Working Party on the Detection of Highly Resistant Microorganisms. Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae. Int. J. Antimicrob. Agents.36(3),205–210 (2010).
  Medline CASGoogle Scholar
• 71  Lo A, Verrall R, Williams J, Stratton C, Della-Latta P, Tang YW. Carbapenem resistance via the bla_KPC-2 gene in Enterobacter cloacae blood culture isolate. South. Med. J.103(5),453–454 (2010).
  MedlineGoogle Scholar
• 72  Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob. Agents Chemother.54,969–976 (2010).
  Medline CASGoogle Scholar
• 73  Nordmann P, Naas T, Poirel L. Global spread of carbapenemase producing Enterobacteriaceae. Emerg. Infect. Dis.17,1791–1798 (2011).
  Medline CASGoogle Scholar
• 74  Naas T, Nordmann P. Analysis of a carbapenem-hydrolyzing class A beta-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. Proc. Natl Acad. Sci. USA91,7693–7697 (1994).
  Medline CASGoogle Scholar
• 75  Radice M, Power P, Gutkind G et al. First class A carbapenemase isolated from Enterobacteriaceae in Argentina. Antimicrob. Agents Chemother.48,1068–1069 (2004).
  Medline CASGoogle Scholar
• 76  Pottumarthy S, Moland ES, Jeretschko S, Swanzy SR, Thomson KS, Fritsche TR. NmcA carbapenem-hydrolyzing enzyme in Enterobacter cloacae in North America. Emerg. Infect. Dis.9,999–1002 (2003).
  Medline CASGoogle Scholar
• 77  Naas T, Cattoen C, Bernusset S, Cuzon G, Nordmann P. First Identification of bla_IMI-1 in an Enterobactercloacae clinical isolate from France. Antimicrob. Agents Chemother.56(3),1664–1665 (2012).
  Medline CASGoogle Scholar
• 78  Rasmussen BA, Bush K, Keeney D et al. Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob. Agents Chemother.40,2080–2086 (1996).
  Medline CASGoogle Scholar
• 79  Yun-Song Y, Xiao-Xing D, Zhi-Hui Z, Ya-Gang C, Lan-Juan L. First isolation of bla_IMI-2 in an Enterobacter cloacae clinical isolate from China. Antimicrob. Agents Chemother.50,1610–1611 (2006).
  MedlineGoogle Scholar
• 80  Nordmann P, Mariotte S, Naas T, Labia R, Nicolas MH. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob. Agents Chemother.37(5),939–946 (1993).
  Medline CASGoogle Scholar
• 81  Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin. Microbiol. Rev.20,440–458 (2007).▪ Focuses on updated information on the epidemiological and biochemical characteristics of carbapenemases of E. cloacae.
  Medline CASGoogle Scholar
• 82  Aubron C, Poirel L, Ash RJ, Nordmann P. Carbapenemase-producing Enterobacteriaceae, U.S. rivers. Emerg. Infect. Dis.11,260–264 (2005).
  Medline CASGoogle Scholar
• 83  Giakkoupi P, Tzouvelekis LS, Tsakris A, Loukova V, Sofianou D, Tzelepi E. IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an clinical strain. Antimicrob. Agents Chemother.44,2247–2253 (2000).
  Medline CASGoogle Scholar
• 84  Bratu S, Landman D, Alam M, Tolentino E, Quale J. Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York. Antimicrob. Agents Chemother.49,776–778 (2005).
  Medline CASGoogle Scholar
• 85  Cornaglia G, Giamarellou H, Rossolini GM. Metallo-beta-lactamases: a last frontier for beta-lactams? Lancet Infect. Dis.11(5),381–393 (2011).
  Medline CASGoogle Scholar
• 86  Deshpande LM, Jones RN, Fritsche TR, Sader HS. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000–2004). Microb. Drug Resist.12(4),223–230 (2006).
  Medline CASGoogle Scholar
• 87  Yan JJ, Ko WC, Chuang CL, Wu JJ. Metallo-beta-lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii. J. Antimicrob. Chemother.50,503–511 (2002).
  Medline CASGoogle Scholar
• 88  Lee MF, Peng CF, Hsu HJ, Chen YH. Molecular characterisation of the metallo-beta-lactamase genes in imipenem-resistant Gram-negative bacteria from a university hospital in southern Taiwan. Int. J. Antimicrob. Agents.32,475–480 (2008).
  Medline CASGoogle Scholar
• 89  Luzzaro F, Docquier JD, Colinon C et al. Emergence in Klebsiella pneumoniae and Enterobacter cloacae clinical isolates of the VIM-4 metallo-beta-lactamase encoded by a conjugative plasmid. Antimicrob. Agents Chemother.48,648–650 (2004).
  Medline CASGoogle Scholar
• 90  Perilli MG, Mezzatesta ML, Marco F et al. Class I integron-borne bla_VIM-1 carbapenemase in a strain of Enterobacter cloacae responsible for a case of fatal pneumonia. Microb. Drug Resist.14(1),45–47 (2008).
  Medline CASGoogle Scholar
• 91  Falcone M, Mezzatesta ML, Perilli MG et al. Infections with VIM-1 metallo-beta-lactamase-producing Enterobacter cloacae and their correlation with clinical outcome. J. Clin. Microbiol.47(11),3514–3519 (2009).
  Medline CASGoogle Scholar
• 92  Panopoulou M, Alepopoulou E, Ikonomidis A, Grapsa A, Paspalidou E, Kartali-Ktenidou S. Emergence of VIM-12 in Enterobacter cloacae. J. Clin. Microbiol.48(9),3414–3415 (2010).
  MedlineGoogle Scholar
• 93  Souli M, Kontopidou FV, Papadomichelakis E, Galani I, Armaganidis A, Giamarellou H. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek university hospital. Clin. Infect. Dis.46,847–854 (2008).
  MedlineGoogle Scholar
• 94  Tato M, Coque TM, Ruiz-Garbajosa P et al. Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity? Clin. Infect. Dis.45,1171–1178 (2007).
  Medline CASGoogle Scholar
• 95  Yong D, Toleman MA, Giske CG et al. Characterization of a new metallo-beta-lactamase gene, bla_NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother.53,5046–5054 (2009).
  Medline CASGoogle Scholar
• 96  Brink AJ, Coetzee J, Clay CG et al. Emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa. J. Clin. Microbiol.50(2),525–527 (2012).
  Medline CASGoogle Scholar
• 97  Bogaerts P, Bouchahrouf W, Rezende de Castro R et al. Emergence of NDM-1-producing Enterobacteriaceae in Belgium. Antimicrob. Agents Chemother.55,3036–3038 (2011).
  Medline CASGoogle Scholar
• 98  Carrer A, Poirel L, Yilmaz M et al. Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob. Agents Chemother.54(3),1369–1373 (2010).
  Medline CASGoogle Scholar
• 99  Poirel L, Castanheira M, Carrër A et al. OXA-163, an OXA-48-related class D beta-lactamase with extended activity toward expanded-spectrum cephalosporins. Antimicrob. Agents Chemother.55(6),2546–2551 (2011).
  Medline CASGoogle Scholar
• 100  Glupczynskia Y, Huanga TD, Bouchahroufa W et al. Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals. Int. J. Antimicrob. Agents39,168–172 (2012).
  MedlineGoogle Scholar
• 101  Poirel L, Ros A, Carrër A et al. Cross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France. J. Antimicrob. Chemother.66,1181–1182 (2011).
  Medline CASGoogle Scholar
• 102  Szabó D, Silveira F, Hujer AM et al. Outer membrane protein changes and efflux pump expression together may confer resistance to ertapenem in Enterobacter cloacae. Antimicrob. Agents Chemother.50(8),2833–2835 (2006).
  Medline CASGoogle Scholar
• 103  Chow JW, Fine MJ, Shlaes DM et al.Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann. Intern. Med.115,585–590 (1991).
  Medline CASGoogle Scholar
• 104  Choi SH, Lee JE, Park SJ et al. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase implications for antibiotic use. Antimicrob. Agents Chemother.52,995–1000 (2008).
  Medline CASGoogle Scholar
• 105  Baucheron S, Imberechts H, Chaslus-Dancla E, Cloeckaert A. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium phage type DT204. Microb. Drug Resist.8,281–289 (2002).
  Medline CASGoogle Scholar
• 106  Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemother.51,1109–1117 (2003).
  Medline CASGoogle Scholar
• 107  Perichon B, Courvalin P, Galimand M. Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob. Agents Chemother.51,2464–2469 (2007).
  Medline CASGoogle Scholar
• 108  Cano ME, Rodríguez-Martínez JM, Aguero J et al. Detection of plasmid-mediated quinolone resistance genes in clinical isolates of Enterobacter spp. in Spain. J. Clin. Microbiol.47(7),2033–2039 (2009).
  Medline CASGoogle Scholar
• 109  Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis.6,629–640 (2006).
  Medline CASGoogle Scholar
• 110  Martínez-Martínez L, Cano ME, Rodríguez-Martínez JM, Calvo J, Pascual A. Plasmid-mediated quinolone resistance. Expert. Rev. Anti-Infect. Ther.6,685–711 (2008).
  Medline CASGoogle Scholar
• 111  Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. Prevalence in the United States of aac(6´)-Ib-cr encoding a ciprofloxacin modifying enzyme. Antimicrob. Agents Chemother.50,3953–3955 (2006).
  Medline CASGoogle Scholar
• 112  Jacoby GA, Chow N, Waites KB. Prevalence of plasmid mediated quinolone resistance. Antimicrob. Agents Chemother.47,559–562 (2003).
  Medline CASGoogle Scholar
• 113  Park YJ, Yu JK, Lee S, Oh EJ, Woo GJ. Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from Korea. J. Antimicrob. Chemother.60,868–871 (2007).
  Medline CASGoogle Scholar
• 114  Nordmann P, Poirel L. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J. Antimicrob. Chemother.56,463–469 (2005).
  Medline CASGoogle Scholar
• 115  Wu JJ, Ko WC, Tsai SH, Yan JJ. Prevalence of plasmid mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob. Agents Chemother.51,1223–1227 (2007).
  Medline CASGoogle Scholar
• 116  Chmelnitsky I, Navon-Venezia S, Strahilevitz J, Carmeli Y. Plasmid-mediated qnrB2 and carbapenemase gene bla_KPC-2 carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates. Antimicrob. Agents Chemother.52(8),2962–2965 (2008).
  Medline CASGoogle Scholar
• 117  Jacoby G, Cattoir V, Hooper D et al.qnr gene nomenclature. Antimicrob. Agents Chemother.52,2297–2299 (2008).
  Medline CASGoogle Scholar
• 118  Neonakis I, Gikas A, Scoulica E, Manios A, Georgiladakis A, Tselentis Y. Evolution of aminoglycoside resistance phenotypes of four Gram-negative bacteria: an 8-year survey in a university hospital in Greece. Int. J. Antimicrob. Agents22,526–531 (2003).
  Medline CASGoogle Scholar
• 119  Kim SY, Park YJ, Yu JK, Kim YS, Han K. Prevalence and characteristics of aac(6´)-Ib-cr in AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens: a multicenter study from Korea. Diagn. Microbiol. Infect. Dis.63,314–318 (2009).
  Medline CASGoogle Scholar
• 120  Galani I, Souli M, Chryssouli Z, Orlandou K, Giamarellou H. Characterization of a new integron containing bla_VIM-1 and aac(6´)-IIc in an Enterobacter cloacae clinical isolate from Greece. J. Antimicrob. Chemother.55,634–638 (2005).
  Medline CASGoogle Scholar
• 121  Xavier B, Dowzicky MJ. Antimicrobial susceptibility among Gram-negative isolates collected from intensive care units in North America, Europe, the Asia–Pacific rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial. Clin. Ther.34(1),124–137 (2012).
  MedlineGoogle Scholar
• 122  Anthony KB, Fishman NO, Linkin DR, Gasink LB, Edelstein PH, Lautenbach E. Clinical and microbiological outcomes of serious infections with multidrugresistant Gram-negative organisms treated with tigecycline. Clin. Infect. Dis.46,567–570 (2008).
  MedlineGoogle Scholar
• 123  Keeney D, Ruzin A, Bradford PA, RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae. Microb. Drug Resist.13(1),1–6 (2007).
  Medline CASGoogle Scholar
• 124  Daurel C, Fiant AL, Brémont S, Courvalin P, Leclercq R. Emergence of an Enterobacter hormaechei strain with reduced susceptibility to tigecycline under tigecycline therapy. Antimicrob. Agents Chemother.53,4953–4954 (2009).
  Medline CASGoogle Scholar
• 125  Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin. Infect. Dis.40(9),1333–1341 (2006). Erratum in: Clin. Infect. Dis.42(12),1819 (2006).
  Google Scholar
• 126  Price DJE, Graham DI. Effect of large doses of colistin sulphomethate on renal function. BMJ4,525–527 (1970).
  Medline CASGoogle Scholar
• 127  Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE. Adverse effects of sodium colistin methate: manifestations and specific reaction rates during 317 courses of therapy. Ann. Intern. Med.72,857–868 (1970).
  Medline CASGoogle Scholar
• 128  Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K. Evaluation of colistin as an agent against multi-resistant Gram negative bacteria. Int. J. Antimicrob. Agents25,11–25 (2005).
  MedlineGoogle Scholar
• 129  Plachouras D, Karvanen M, Friberg LE et al. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria. Antimicrob. Agents Chemother.53(8),3430–3436 (2009).
  Medline CASGoogle Scholar
• 130  Groisman EA, Kayser J, Soncini FC. Regulation of polymyxin resistance and adaptation to low-Mg²⁺ environments. J. Bacteriol.179(22),7040–7045 (1997).
  Medline CASGoogle Scholar
• 131  Lo-Ten-Foe JR, de Smet AM, Diederen BM, Kluytmans JA, van Keulen PH. Comparative evaluation of the Vitek 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob. Agents Chemother.51(10),3726–3730 (2007).
  Medline CASGoogle Scholar
• 132  Tascini C, Urbani L, Biancofiore G et al. Colistin in combination with rifampin and imipenem for treating a bla_VIM-1 metallo-beta-lactamase-producing Enterobacter cloacae disseminated infection in a liver transplant patient. Minerva Anestesiol.74(1–2),47–49 (2007).
  MedlineGoogle Scholar
• 133  Centers for Disease Control and Prevention. Guidance for control of infections with carbapenem-resistant or carbapenemase producing Enterobacteriaceae in acute care facilities. Morb. Mortal. Wkly Rep.58,256–260 (2009).
  MedlineGoogle Scholar
• 134  Lucet JC, Decre D, Fichelle A et al. Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a university hospital. Clin. Infect. Dis.29,1411–1418 (1999).
  Medline CASGoogle Scholar
• 135  Samra Z, Bahar J, Madar-Shapiro L, Aziz N, Israel S, Bishara J. Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae. J. Clin. Microbiol.46,3110–3111 (2008).
  Medline CASGoogle Scholar
• 201  Euzéby JP. List of prokaryotic names with standing in nomenclature – genus Enterobacter. www.bacterio.cict.fr/e/enterobacter.html
  Google Scholar
• 202  The European Committee on Antimicrobial Susceptibility Testing. www.eucast.org
  Google Scholar